Form D · Other Health Care

Sword Bio, Inc.

Carmel, IN · CIK 0001324536

Offering snapshot reported Jun 26, 2023 · SEC filing

Reported sold
$50K
Offering amount: $1.5M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 15, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 26, 2023Initial$50,000No comparison1SEC filing
Mar 27, 2018Initial$1,526,603No comparison2SEC filing
May 13, 2015Initial$150,000No comparison1SEC filing
Dec 28, 2012Initial$1,274,971No comparison16SEC filing
Oct 13, 2009Initial$435,831No comparison7SEC filing
Oct 30, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Apr 13, 2006PaperNot reportedNo comparisonNot reported
Apr 19, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-485086

Source: Form D, filed Jun 26, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sidney Braginsky Director
David Dingott Director, Executive
Joseph Falkenstein Director
Edward Grogg Director
Gail Page Director
Mel Schatz Director
Michael Shepard Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
13295 Illinois Street Suite 103
Carmel, IN, 46032